A Study to Compare the Bioavailability of Epinephrine Following a Single Nasal Dose of FMXIN002 Microspheres Powder 3.6mg, and 4mg With EpiPen 0.3mg Intramuscular Injection in Healthy Adults
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Epinephrine (Primary)
- Indications Anaphylaxis
- Focus Pharmacodynamics
- Acronyms NP-006-Epinephrine study
Most Recent Events
- 20 Mar 2024 Status changed from recruiting to completed.
- 03 Jan 2024 Status changed from completed to recruiting.
- 08 Dec 2023 New trial record